Lakewood Amedex Biotherapeutics Inc has split its stock once since its initial public offering (IPO). The stock split of Lakewood Amedex Biotherapeutics Inc occurred on June 22, 2026 on a 1-for-10 basis, meaning that for 10 shares of LABT owned pre-split, shareholders then owned 1 share.
This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Lakewood Amedex Biotherapeutics Inc's total market capitalization.
The answer will depend on the decisions of the company's managers and market volatility. Lakewood Amedex Biotherapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when LABT stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Lakewood Amedex Biotherapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
